SCHEMBL31003166

SCHEMBL31003166

O=C(O)c1ccc(CN2CCC(F)(F)CC2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.49
HRH3 Q9Y5N1 2/20 0.47
HIF1A Q16665 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
THPO P40225 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31003202 0.88 HRH3 (0.49) HRH3HIF1AMEN1KMT2ACYP1A2
SCHEMBL31725234 0.84 HRH3 (0.46) HRH3HIF1AMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL4610066 0.82 HRH3 (0.46) P4HTMHRH3HIF1AMEN1KMT2A
SCHEMBL31003347 0.80 HRH3 (0.43) HRH3HIF1AMEN1KMT2AEPAS1
SCHEMBL27747238 0.80 P4HTM (0.51) P4HTMHRH3HIF1AMEN1KMT2A
SCHEMBL22675550 0.80 HIF1A (0.60) P4HTMHRH3HIF1AMEN1KMT2A
SCHEMBL29852315 0.80 SSTR5 (0.41) P4HTMHRH3HIF1AMEN1KMT2A
Hydrochloric Acid SCHEMBL29927909 0.79 SSTR5 (0.40) P4HTMHRH3HIF1AMEN1KMT2A
SCHEMBL3508945 0.77 KMT2A (0.56) HRH3MEN1KMT2AALDH1A1MAPT
SCHEMBL16345634 0.77 TRPV6 (0.48) HRH3MEN1KMT2AGRM2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658656-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES Beone Medicines I GmbH (CH) 2025-12-10 EP disclosed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 US disclosed
WO-2024160276-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEIGENE, LTD. (KY) 2024-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK P4HTM 4730/4885HRH3 1257/4885HIF1A 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.